July 05, 2017
Chinese biopharmaceutical company Sinovac bribed Chinese officials to further a clinical trial for a vaccine it was developing and then lied to its investors about doing so, causing stocks to plunge when the truth came out, a potential class of investors told a New Jersey federal court Monday.